AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Oct 16, 2022.
The trade happened on Sep 12, 2022, 34 days before it was made public.
REGN has moved +3.4% since the trade date, from $710.74 to $735.20 (Oct 2, 2026 close).
- Traded
- Sep 12, 2022
- Disclosed
- Oct 16, 2022
- Filing delay
- 34 days
- Price since
- +3.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (24)
- SellABMD$1K-$15KOct 16, 2022
- BuyADP$1K-$15KOct 16, 2022
- BuyALNY$1K-$15KOct 16, 2022
- SellBHP$1K-$15KOct 16, 2022
- SellBX$1K-$15KOct 16, 2022
- SellCRM$1K-$15KOct 16, 2022
- SellCTSH$1K-$15KOct 16, 2022
- SellCVET$1K-$15KOct 16, 2022
- SellDE$1K-$15KOct 16, 2022
- SellDXCM$1K-$15KOct 16, 2022
- SellFIS$1K-$15KOct 16, 2022
- BuyFLYW$1K-$15KOct 16, 2022
- SellHCA$1K-$15KOct 16, 2022
- SellMDB$1K-$15KOct 16, 2022
- SellMGY$1K-$15KOct 16, 2022
- SellNVDA$1K-$15KOct 16, 2022
- SellORCL$1K-$15KOct 16, 2022
- SellPCTY$1K-$15KOct 16, 2022
- SellSAP$1K-$15KOct 16, 2022
- BuySTAG$1K-$15KOct 16, 2022
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.